tradingkey.logo

ENDRA Life Sciences Inc

NDRA
4.990USD
-0.180-3.48%
Close 11/04, 16:00ETQuotes delayed by 15 min
3.75MMarket Cap
LossP/E TTM

ENDRA Life Sciences Inc

4.990
-0.180-3.48%

More Details of ENDRA Life Sciences Inc Company

ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The Company's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into the body during an MRI scan. The use of RF energy allows its TAEUS technology to penetrate deep into tissue, enabling the imaging of human anatomy at depths equivalent to those of conventional ultrasound. The RF pulses are absorbed by tissue and converted into ultrasound signals. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD), a chronic liver disease spectrum. It is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

ENDRA Life Sciences Inc Info

Ticker SymbolNDRA
Company nameENDRA Life Sciences Inc
IPO dateJun 28, 2017
CEOMr. Alexander Y. Tokman
Number of employees21
Security typeOrdinary Share
Fiscal year-endJun 28
Address3600 Green Ct Ste 350
CityANN ARBOR
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code48105-2440
Phone17343350468
Websitehttps://www.endrainc.com/
Ticker SymbolNDRA
IPO dateJun 28, 2017
CEOMr. Alexander Y. Tokman

Company Executives of ENDRA Life Sciences Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Independent Director
Independent Director
70.81K
+1200.99%
Mr. Michael Milos Thornton
Mr. Michael Milos Thornton
Chief Technology Officer
Chief Technology Officer
20.00
--
Mr. Alexander Y. Tokman
Mr. Alexander Y. Tokman
Chairman of the Board, Acting Chief Executive Officer
Chairman of the Board, Acting Chief Executive Officer
5.00
--
Mr. Michael Harsh
Mr. Michael Harsh
Independent Director
Independent Director
2.00
-99.96%
Mr. Louis J. Basenese
Mr. Louis J. Basenese
Independent Director
Independent Director
--
--
Ms. Yvonne Briggs
Ms. Yvonne Briggs
Investor Relations
Investor Relations
--
--
Mr. Richard Jacroux
Mr. Richard Jacroux
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Independent Director
Independent Director
70.81K
+1200.99%
Mr. Michael Milos Thornton
Mr. Michael Milos Thornton
Chief Technology Officer
Chief Technology Officer
20.00
--
Mr. Alexander Y. Tokman
Mr. Alexander Y. Tokman
Chairman of the Board, Acting Chief Executive Officer
Chairman of the Board, Acting Chief Executive Officer
5.00
--
Mr. Michael Harsh
Mr. Michael Harsh
Independent Director
Independent Director
2.00
-99.96%
Mr. Louis J. Basenese
Mr. Louis J. Basenese
Independent Director
Independent Director
--
--
Ms. Yvonne Briggs
Ms. Yvonne Briggs
Investor Relations
Investor Relations
--
--

Revenue Breakdown

No Data
No Data
By Business
By Region
No Data

Shareholding Stats

Updated: Thu, Oct 30
Updated: Thu, Oct 30
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
ATW Partners LLC
9.95%
Lipman (John Carter)
6.52%
DiGiandomenico (Anthony)
6.07%
Geode Capital Management, L.L.C.
0.44%
UBS Financial Services, Inc.
0.40%
Other
76.62%
Shareholders
Shareholders
Proportion
ATW Partners LLC
9.95%
Lipman (John Carter)
6.52%
DiGiandomenico (Anthony)
6.07%
Geode Capital Management, L.L.C.
0.44%
UBS Financial Services, Inc.
0.40%
Other
76.62%
Shareholder Types
Shareholders
Proportion
Individual Investor
12.60%
Private Equity
9.95%
Investment Advisor
0.65%
Investment Advisor/Hedge Fund
0.44%
Corporation
0.06%
Other
76.31%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
24
12.65K
1.08%
+1.88K
2025Q2
34
22.09K
2.99%
+12.79K
2025Q1
37
5.94K
0.98%
+652.00
2024Q4
38
889.00
0.17%
-4.90K
2024Q3
39
6.39K
8.81%
+5.79K
2024Q2
39
2.03K
9.18%
+1.72K
2024Q1
33
352.00
9.94%
+101.00
2023Q4
35
276.00
9.44%
+68.00
2023Q3
37
286.00
9.99%
+78.00
2023Q2
39
314.00
10.85%
+151.00
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
DiGiandomenico (Anthony)
5.44K
0.72%
+5.38K
+9125.42%
Jun 11, 2025
Geode Capital Management, L.L.C.
5.13K
0.68%
+594.00
+13.09%
Aug 31, 2025
UBS Financial Services, Inc.
4.70K
0.62%
+4.70K
--
Jun 30, 2025
The Vanguard Group, Inc.
116.00
0.02%
--
--
Aug 31, 2025
S.H.N. Financial Investments Ltd
686.00
0.09%
+686.00
--
Jun 04, 2024
Northwestern Mutual Capital, LLC
35.00
0%
+35.00
--
Jun 30, 2025
Thornton (Michael Milos)
20.00
0%
--
--
Mar 24, 2025
BofA Global Research (US)
6.00
0%
+2.00
+50.00%
Jun 30, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Aug 16, 2024
Merger
50→1
Aug 16, 2024
Merger
50→1
Date
Type
Ratio
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Aug 16, 2024
Merger
50→1
Aug 16, 2024
Merger
50→1
Aug 16, 2024
Merger
50→1
Aug 16, 2024
Merger
50→1
Dec 06, 2022
Merger
20→1
Dec 06, 2022
Merger
20→1
View more
KeyAI